Biogen shares soar on landmark Alzheimer's data

Biogen shares soar on landmark Alzheimer's data

Shares of Biogen soared more than 40% after a surprise successful trial of its experimental Alzheimer's drug.


Share:

Comments

Comentarios de Facebook